Воспалительные заболевания тонкого кишечника: недифференцированные и недифференцируемые энтерит и энтероколит
Воспалительные заболевания тонкого кишечника: недифференцированные и недифференцируемые энтерит и энтероколит
Вялов С.С. Воспалительные заболевания тонкого кишечника: недифференцированные и недифференцируемые энтерит и энтероколит. Consilium Medicum. 2017; 19 (8): 14–18. DOI: 10.26442/2075-1753_19.8.14-18
________________________________________________
Vialov S.S. Inflammatory diseases of the small intestine: undifferentiated and undifferentiable enteritis and enterocolitis. Consilium Medicum. 2017; 19 (8): 14–18. DOI: 10.26442/2075-1753_19.8.14-18
Воспалительные заболевания тонкого кишечника: недифференцированные и недифференцируемые энтерит и энтероколит
Вялов С.С. Воспалительные заболевания тонкого кишечника: недифференцированные и недифференцируемые энтерит и энтероколит. Consilium Medicum. 2017; 19 (8): 14–18. DOI: 10.26442/2075-1753_19.8.14-18
________________________________________________
Vialov S.S. Inflammatory diseases of the small intestine: undifferentiated and undifferentiable enteritis and enterocolitis. Consilium Medicum. 2017; 19 (8): 14–18. DOI: 10.26442/2075-1753_19.8.14-18
В статье обсуждаются вопросы диагностики и лечения воспалительных заболеваний тонкого кишечника, дифференциальный диагноз. Существуют практические трудности в диагностике патологии тонкой кишки. Необходим рутинный скрининг патологии кишечника у пациентов с сохраняющейся симптоматикой. Для выявления воспалительных заболеваний кишечника целесообразно использовать кальпротектин, пассаж бария и капсульную эндоскопию.
The article discusses the diagnosis and treatment of inflammatory diseases of the small intestine, the differential diagnosis. There are practical difficulties in the diagnosis of pathology of the small intestine. Required routine screening of the intestinal pathology in patients with persistent symptoms. To identify inflammatory bowel disease it is advisable to use calprotectin, the passage of barium and capsule endoscopy.
1. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012; 10: 712.
2. Fine KD, Seidel RH, Do K. The prevalence, anatomic distribution, and diagnosis of colonic causes of chronic diarrhea. Gastrointest Endosc 2000; 51: 318.
3. Bhutta ZA, Ghishan F, Lindley K et al. Persistent and chronic diarrhea and malabsorption: Working Group report of the second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2004; 39 (Suppl. 2): S711.
4. Binder HJ. Causes of chronic diarrhea. N Engl J Med 2006; 355: 236.
5. Farthing MJ. Diarrhoea: a significant worldwide problem. Int J Antimicrob Agents 2000; 14: 65.
6. Habba SF. Chronic diarrhea: identifying a new syndrome. Am J Gastroenterol 2000; 95: 2140.
7. Hungin AP, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther 2003; 17: 643.
8. Burgmann T, Clara I, Graff L et al. The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis – how much is irritable bowel syndrome? Clin Gastroenterol Hepatol 2006; 4: 614.
9. Hahn BA, Saunders WB, Maier WC. Differences between individuals with self-reported irritable bowel syndrome (IBS) and IBS-like symptoms. Dig Dis Sci 1997; 42: 2585.
10. Schiller LR. Chronic diarrhea. Gastroenterology 2004; 127: 287.
11. Mearin F, Lacy BE, Chang L et al. Bowel Disorders. Gastroenterology 2016; 150 (6): 1393–1407e5.
12. Gibbons T, Fuchs GJ. Chronic enteropathy: clinical aspects. Nestle Nutr Workshop Ser Pediatr Program 2007; 59: 89.
13. Preidis GA, Hill C, Guerrant RL et al. Probiotics, enteric and diarrheal diseases, and global health. Gastroenterology 2011; 140: 8.
14. Leeds JS, Oppong K, Sanders DS. The role of fecal elastase-1 in detecting exocrine pancreatic disease. Nat Rev Gastroenterol Hepatol 2011; 8: 405.
15. Lappinga PJ, Abraham SC, Murray JA et al. Small intestinal bacterial overgrowth: histopathologic features and clinical correlates in an underrecognized entity. Arch Pathol Lab Med 2010; 134: 264.
16. Mosli MH, Zou G, Garg SK et al. C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis. Am J Gastroenterol 2015; 110: 802.
17. Poullis A, Foster R, Mendall MA, Fagerhol MK. Emerging role of calprotectin in gastroenterology. J Gastroenterol Hepatol 2003; 18: 756.
18. Beattie RM, Walker-Smith JA, Murch SH. Indications for investigation of chronic gastrointestinal symptoms. Arch Dis Child 1995; 73: 354.
19. Mowat C, Cole A, Windsor A et al. Guidelines for the management of inflammatory bowel disease in adults. Gut 2011; 60: 571.
20. ASGE Standards of Practice Committee, Shen B, Khan K et al. The role of endoscopy in the management of patients with diarrhea. Gastrointest Endosc 2010; 71: 887.
21. Van Gossum A, Munoz-Navas M, Fernandez-Urien I et al. Capsule endoscopy versus colonoscopy for the detection of polyps and cancer. N Engl J Med 2009; 361: 264.
22. Enns RA, Hookey L, Armstrong D et al. Clinical Practice Guidelines for the Use of Video Capsule Endoscopy. Gastroenterology 2017; 152: 497.
23. O'Connor OJ, McSweeney SE, McWilliams S et al. Role of radiologic imaging in irritable bowel syndrome: evidence-based review. Radiology 2012; 262: 485.
24. Levesque BG, Cipriano LE, Chang SL et al. Cost effectiveness of alternative imaging strategies for the diagnosis of small-bowel Crohn's disease. Clin Gastroenterol Hepatol 2010; 8: 261.
25. Siddiki HA, Fidler JL, Fletcher JG et al. Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn's disease. AJR Am J Roentgenol 2009; 193: 113.
________________________________________________
1. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012; 10: 712.
2. Fine KD, Seidel RH, Do K. The prevalence, anatomic distribution, and diagnosis of colonic causes of chronic diarrhea. Gastrointest Endosc 2000; 51: 318.
3. Bhutta ZA, Ghishan F, Lindley K et al. Persistent and chronic diarrhea and malabsorption: Working Group report of the second World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr 2004; 39 (Suppl. 2): S711.
4. Binder HJ. Causes of chronic diarrhea. N Engl J Med 2006; 355: 236.
5. Farthing MJ. Diarrhoea: a significant worldwide problem. Int J Antimicrob Agents 2000; 14: 65.
6. Habba SF. Chronic diarrhea: identifying a new syndrome. Am J Gastroenterol 2000; 95: 2140.
7. Hungin AP, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther 2003; 17: 643.
8. Burgmann T, Clara I, Graff L et al. The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis – how much is irritable bowel syndrome? Clin Gastroenterol Hepatol 2006; 4: 614.
9. Hahn BA, Saunders WB, Maier WC. Differences between individuals with self-reported irritable bowel syndrome (IBS) and IBS-like symptoms. Dig Dis Sci 1997; 42: 2585.
10. Schiller LR. Chronic diarrhea. Gastroenterology 2004; 127: 287.
11. Mearin F, Lacy BE, Chang L et al. Bowel Disorders. Gastroenterology 2016; 150 (6): 1393–1407e5.
12. Gibbons T, Fuchs GJ. Chronic enteropathy: clinical aspects. Nestle Nutr Workshop Ser Pediatr Program 2007; 59: 89.
13. Preidis GA, Hill C, Guerrant RL et al. Probiotics, enteric and diarrheal diseases, and global health. Gastroenterology 2011; 140: 8.
14. Leeds JS, Oppong K, Sanders DS. The role of fecal elastase-1 in detecting exocrine pancreatic disease. Nat Rev Gastroenterol Hepatol 2011; 8: 405.
15. Lappinga PJ, Abraham SC, Murray JA et al. Small intestinal bacterial overgrowth: histopathologic features and clinical correlates in an underrecognized entity. Arch Pathol Lab Med 2010; 134: 264.
16. Mosli MH, Zou G, Garg SK et al. C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis. Am J Gastroenterol 2015; 110: 802.
17. Poullis A, Foster R, Mendall MA, Fagerhol MK. Emerging role of calprotectin in gastroenterology. J Gastroenterol Hepatol 2003; 18: 756.
18. Beattie RM, Walker-Smith JA, Murch SH. Indications for investigation of chronic gastrointestinal symptoms. Arch Dis Child 1995; 73: 354.
19. Mowat C, Cole A, Windsor A et al. Guidelines for the management of inflammatory bowel disease in adults. Gut 2011; 60: 571.
20. ASGE Standards of Practice Committee, Shen B, Khan K et al. The role of endoscopy in the management of patients with diarrhea. Gastrointest Endosc 2010; 71: 887.
21. Van Gossum A, Munoz-Navas M, Fernandez-Urien I et al. Capsule endoscopy versus colonoscopy for the detection of polyps and cancer. N Engl J Med 2009; 361: 264.
22. Enns RA, Hookey L, Armstrong D et al. Clinical Practice Guidelines for the Use of Video Capsule Endoscopy. Gastroenterology 2017; 152: 497.
23. O'Connor OJ, McSweeney SE, McWilliams S et al. Role of radiologic imaging in irritable bowel syndrome: evidence-based review. Radiology 2012; 262: 485.
24. Levesque BG, Cipriano LE, Chang SL et al. Cost effectiveness of alternative imaging strategies for the diagnosis of small-bowel Crohn's disease. Clin Gastroenterol Hepatol 2010; 8: 261.
25. Siddiki HA, Fidler JL, Fletcher JG et al. Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn's disease. AJR Am J Roentgenol 2009; 193: 113.
Авторы
С.С.Вялов
ФГАОУ ВО «Российский университет дружбы народов». 117198, Россия, Москва, ул. Миклухо-Маклая, д. 6 svialov@mail.ru
________________________________________________
S.S.Vialov
People’s Friendship University of Russia. 117198, Russian Federation, Moscow, ul. Miklukho-Maklaya, d. 6 svialov@mail.ru